跳至主要内容
临床试验/NCT06918652
NCT06918652招募中不适用

Surgical vs Endoscopic Treatments as ImmunoModulating Interventions in High-Risk Acute Calculous Cholecystitis

Fondazione IRCCS Policlinico San Matteo di Pavia2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2023年10月20日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
80
试验地点
2
主要终点
The primary objective of the study is to find if TUGD with LAMSs, compared to LC, has a lower inflammatory and immunologic impact on high-risk patients with ACC.

研究概览

简要总结

Randomized controlled trial on high-risk patients with ACC. Consecutive patients with a diagnosis of ACC, if they meet the inclusion and exclusion criteria, will be randomized to receive Laparoscopic cholecystectomy (LC) or transmural ultrasound-guided gallbladder drainage (TUGD) with lumen-apposing self-expandable metal stents (LAMSs) within 10 days from onset of symptoms. Blood cultures will be performed at the time of admission, just before the procedure, 24 ± 3h after procedure, 72 ± 3h after procedure. Bile samples will be taken during the procedure for microbiological exam and culture. Blood samples will collected from all patients at the time of admission, just before the procedure, 24 ± 3h after procedure, 72 ± 3h after procedure.

The follow-up will be performed after 30 days and after 6 months from intervention with an outpatient medical examination.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • have a diagnosis of ACC as defined by 2018 Tokyo Guidelines criteria
  • be ≥ 18 years old
  • have a POSSUM PS ≥ 25
  • onset of symptoms <= 7 days before Emergency Department (ED) admission
  • provide signed and dated informed consent form
  • willing to comply with all study procedures and be available for the duration of the study
  • have an Israelian Score (IS) (Table 3) for the risk of main bile duct stones <2 or an IS =2 and an EUS or a MRCP negative for main bile duct stones

排除标准

  • Pregnancy
  • Patients unwilling to undergo follow-up assessments
  • Patients diagnosed with concomitant pancreatitis
  • Acute cholecystitis not related to a gallstone etiology
  • Onset of symptoms >7 days before ED admission
  • Altered anatomy of the upper gastrointestinal tract due to surgery of the esophagus, stomach and duodenum
  • Previous drainage of the gallbladder
  • Biliary peritonitis

结局指标

主要结局

The primary objective of the study is to find if TUGD with LAMSs, compared to LC, has a lower inflammatory and immunologic impact on high-risk patients with ACC.

时间窗: baseline, pre-surgery, day 3

Difference between the plasma elastase concentration before surgery and on the third postoperative day

次要结局

  • difference between the plasma concentration biochemical and immunological parameters(baseline, pre-surgery, day 1, day 3)
  • 30-day postoperative complication rate according to Clavien-Dindo(day 30)
  • 30-day postoperative biliary complication rate(day 30)
  • 30-day postoperative mortality rate(day 30)
  • Intraoperative complication rate(day 0)
  • Failure rate of performing the procedure(day 0)
  • Operative times(through study completion, an average of 2 years)
  • Postoperative length of stay (PO-LOS)(through study completion, an average of 2 years)
  • Total length of stay (T-LOS)(through study completion, an average of 2 years)
  • Total readmission rate within 6 months(6 Months after procedure)
  • Readmission rate within 6 months due to Gallstones Relates Events (GRE)(6 Months after procedure)
  • Outcomes of blood and bile cultures (to define the infectious state of the patient)(Baseline, pre-surgery, during the surgery, day 1, day 3)
  • Post-operative pain(through study completion, an average of 2 years)

研究者

发起方
Fondazione IRCCS Policlinico San Matteo di Pavia
申办方类型
Other
责任方
Principal Investigator
主要研究者

Luca Ansaloni

MD

Fondazione IRCCS Policlinico San Matteo di Pavia

研究点 (2)

Loading locations...

相似试验